Professional Documents
Culture Documents
I. Introduction
A. Intrinsic Resistance
o Examples: Gram-negative bacteria vs. vancomycin, Mycoplasma vs. beta-
lactams
B. Acquired Resistance
o Mechanisms: chromosomal mutations, extrachromosomal genes
(plasmids, transposons)
o Horizontal gene transfer
V. Multidrug Resistance
Cross-resistance patterns
Role of plasmids, transposons, and integrons in horizontal gene transfer
VII. Conclusion
The Problem:
Types of Resistance:
Resistance Mechanisms:
Conclusion:
Bacteria possess inherent structural properties that can prevent antibiotics from
working. Examples include:
A. Chromosomal Mutations:
Spontaneous mutations in the bacterial chromosome can occur due to various factors.
These mutations can alter antibiotic targets, such as modifications to penicillin-binding
proteins (PBPs) in Streptococcus pneumoniae, conferring resistance to penicillins.
These are mobile pieces of DNA that can spread resistance genes between bacteria:
A. Beta-lactams:
Production of beta-lactamase enzymes: These enzymes (classes A, B, C, D)
break down the beta-lactam ring, rendering the antibiotic ineffective.
Target modifications: Alterations in penicillin-binding proteins (PBPs) can
prevent the antibiotic from binding.
B. Aminoglycosides:
Aminoglycoside-modifying enzymes: These enzymes modify the antibiotic
structure (acetylation, adenylation, phosphorylation) rendering it inactive.
Ribosomal target modifications: Changes in the 16S ribosomal RNA (rRNA)
can prevent the antibiotic from binding to the ribosome.
C. Tetracyclines:
Efflux pumps: These pumps actively transport tetracyclines out of the bacterial
cell.
Ribosomal protection proteins: These proteins modify ribosomes, preventing
tetracycline binding.
D. Macrolides, Lincosamides, Streptogramins (MLS):
Ribosomal methylation: Methylation modifications on the ribosome decrease
drug binding.
Erythromycin esterase enzymes: These enzymes specifically inactivate
macrolide antibiotics.
Modifications in Drug Targets:
This mechanism involves changes in the antibiotic's target site, like receptors or
regions on enzymes and ribosomes where the antibiotic binds. Imagine an
antibiotic as a key fitting a specific lock on a bacteria's cell. Mutations or enzymes
can modify this lock so the key no longer fits.
Target Mutations: Random changes in the bacteria's DNA can alter the
structure of the target site. For example, variations in the 16S ribosomal RNA can
make it difficult for macrolide antibiotics to bind.
Modification Enzymes: Some bacteria produce enzymes that chemically alter
the target site, further hindering antibiotic attachment.
Bacteria can fortify their cell walls, making it harder for antibiotics to penetrate
and reach their targets. Think of it like building thicker castle walls to keep
invaders out.
Reduced Porin Channels: Gram-negative bacteria have special channels
(porins) that control what enters the cell. By reducing these channels, they limit
antibiotic uptake.
Lipopolysaccharide Modifications: The outer membrane of these bacteria can
be modified with extra molecules, creating another barrier for antibiotics.